Incyte (INCY) Gross Margin (2012 - 2026)

Incyte (INCY) posted Gross Margin of 91.79% for Q1 2026, little changed on a QoQ basis from 91.96% in Q4 2025, and down 126.0% year-over-year from 353.03% in Q1 2025.

Incyte (INCY) Gross Margin (2012 - 2026) Analysis & Trends

Incyte's Gross Margin history runs 15 years deep, the most recent figure standing at 91.79% for Q1 2026.

  • Quarterly Gross Margin fell 126.0% year-over-year to 91.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 92.47% (down 18.0% YoY) and the FY2025 annual result came in at 92.76%, up 12.0% from the prior year.
  • Gross Margin was 91.79% for Q1 2026 at Incyte, roughly flat from 91.96% in the prior quarter.
  • Across five years, Gross Margin topped out at 94.44% in Q2 2022 and bottomed at 91.79% in Q1 2026.
  • A 5-year average of 93.04% and a median of 93.05% in 2025 frame the typical range for Gross Margin.
  • Annual changes were most pronounced in 2022 — Gross Margin tumbled 173 bps — and 2025, when it soared 86 bps.
  • Incyte's Gross Margin stood at 93.62% in 2022, then retreated by 1 bps to 93.12% in 2023, then slipped by 1 bps to 92.49% in 2024, then declined by 1 bps to 91.96% in 2025, then slipped by 0 bps to 91.79% in 2026.
  • Business Quant data shows INCY's Gross Margin at 91.79% in Q1 2026, 91.96% in Q4 2025, and 92.75% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 88.95%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 91.79%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 90.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 91.79%

Historic Data

Download Data
DateValue
Mar 31, 2026 91.79%
Dec 31, 2025 91.96%
Sep 30, 2025 92.75%
Jun 30, 2025 93.52%
Mar 31, 2025 93.05%
Dec 31, 2024 92.49%
Sep 30, 2024 92.44%
Jun 30, 2024 92.66%
Mar 31, 2024 93.08%
Dec 31, 2023 93.12%
Sep 30, 2023 93.46%
Jun 30, 2023 92.84%
Mar 31, 2023 92.97%
Dec 31, 2022 93.62%
Sep 30, 2022 93.37%
Jun 30, 2022 94.44%
Mar 31, 2022 94.19%
Dec 31, 2021 94.92%
Sep 30, 2021 95.10%
Jun 30, 2021 94.61%